You are here: Industry Insights > COVID-19

News List

COVID-19: SKEMA Among the First Global Business Schools to Offer All Courses Online in Five Continents prnasia
March 23, 2020
With the temporary closure of SKEMA's Suzhou campus in China in mid-January, SKEMA had already set up a comprehensive distance learning system to ensure the continuity of studies for its 550 students present on the campus at that time. Since then, they ha
FPT Donates 2,000 Quarantine Rooms and Cash to Fight COVID-19 prnasia
March 23, 2020
Vietnam's largest tech firm, FPT, on Sunday announced it had dedicated its 2,000-room university dormitory as a quarantine site and US$850,000 in medical supplies to support the Government's fight against coronavirus (COVID-19).
Roche initiates Phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia worldpharmanews
March 23, 2020
Roche is working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled Phase III clinical trial in collaboration ...
FDA continues to facilitate development of COVID-19 treatments worldpharmanews
March 23, 2020
The U.S. Food and Drug Administration continues to play a critical role in the multifaceted all-of-government response to the COVID-19 pandemic.
USP Offers Support for Developers of COVID-19 Antiviral Drugs and Vaccines americanpharmaceuticalreview
March 23, 2020
The U.S. Pharmacopeia (USP) is providing free technical assistance to developers of medical treatments such as antiviral drugs and vaccines that can support the public health response to the COVID-19 pandemic.
Roivant Develops Gimsilumab for ARDS Associated with COVID-19 americanpharmaceuticalreview
March 23, 2020
Roivant Sciences has engaged with regulators in the United States, Europe, and Asia to rapidly advance the clinical development of gimsilumab for the treatment ...
CENTOGENE Announces Commencement of Testing for COVID-19 americanpharmaceuticalreview
March 23, 2020
CENTOGENE will commence testing for the novel coronavirus, or COVID-19. Testing for the virus is part of the Company’s initiative to help local, national ...
Study evaluates if siltuximab benefits COVID-19 patients with respiratory complications europeanpharmaceuticalreview
March 23, 2020
The SISCO study will assess if the anti-IL-6 antibody siltuximab can aid patients suffering Acute Respiratory Distress Syndrome as a complication of the COVID-19 coronavirus.
Indian Prime Minister Narendra Modi calls for citizen curfew to fight coronavirus pharmaceutical-technology
March 23, 2020
Indian Prime Minister Narendra Modi has urged people to opt for a self-imposed citizen curfew on 22 March (Sunday) from 7am to 9pm, in a preparatory move to fight the pandemic coronavirus Covid-19 in the country.
Israel approves import of generic of AbbVie’s HIV drug for Covid-19 pharmaceutical-technology
March 23, 2020
Israel health ministry has approved the licensing of a generic version of AbbVie’s HIV drug Kaletra to treat Covid-19, as the cases in the country exceed 500.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page